Genetically modified non-human having humanized gamma and delta TCR variable genes
US-2024114883-A1 · Apr 11, 2024 · US
US11793179B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11793179-B2 |
| Application number | US-202117248071-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 7, 2021 |
| Priority date | Jan 7, 2020 |
| Publication date | Oct 24, 2023 |
| Grant date | Oct 24, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Livestock animals and progeny thereof comprising at least one edited chromosomal sequence that alters expression or activity of a somatostatin receptor (SSTR) protein are provided. Livestock animal cells that contain such edited chromosomal sequences are also provided. The livestock animals have improved growth performance and weight gain. Methods for producing livestock animals with increased growth performance are also provided.
Opening claim text (preview).
What is claimed is: 1. A genetically edited male or female pig, or progeny thereof, comprising an edited chromosomal sequence that reduces or eliminates expression or activity of a somatostatin receptor 2 (SSTR2) protein, wherein growth performance of the male pig comprising the edited chromosomal sequence is improved when compared to a non-edited male pig. 2. The genetically edited male or female pig of claim 1 , wherein the edited chromosomal sequence comprises a substitution, insertion, or deletion of one or more nucleotides in the SSTR2 coding sequence. 3. The genetically edited male or female pig of claim 1 , wherein the edited chromosomal sequence eliminates the expression or activity of the SSTR2 protein. 4. The genetically edited male or female pig of claim 1 , wherein the edited chromosomal sequence comprises no exogenously introduced sequence. 5. The genetically edited male or female pig of claim 1 , wherein the pig further comprises an edited chromosomal sequence that reduces or eliminates expression or activity of a SSTR1, SSTR3, SSTR4, or SSTR5 protein. 6. The genetically edited male or female pig of claim 1 , wherein the pig is heterozygous or homozygous for the edited chromosomal sequence. 7. The genetically edited male or female pig of claim 1 , wherein the pig is a male pig. 8. The genetically edited male or female pig of claim 1 , wherein the edited chromosomal sequence comprises SEQ ID NO: 3 or 4. 9. A cell of the genetically edited male or female pig of claim 1 . 10. The cell of claim 9 , wherein the edited chromosomal sequence comprises a substitution, insertion, or deletion of one or more nucleotides in the SSTR2 coding sequence. 11. The cell of claim 9 , wherein the cell further comprises an edited chromosomal sequence that reduces or eliminates expression or activity of a SSTR1, SSTR3, SSTR4, or SSTR5 protein. 12. The cell of claim 9 , wherein the cell is heterozygous or homozygous for the edited chromosomal sequence. 13. The cell of claim 9 , further comprising a conditional knock-out system for conditional expression of the SSTR2 protein. 14. The cell of claim 9 , wherein the cell is a sperm cell or an egg cell. 15. The cell of claim 9 , wherein the cell is a somatic cell. 16. The cell of claim 9 , wherein the edited chromosomal sequence comprises SEQ ID NO: 3 or 4. 17. A method of generating a male or female pig comprising: editing a chromosomal sequence of the male or female pig to create a modification which reduces or eliminates the expression or activity of a somatostatin receptor 2 (SSTR2) protein, wherein growth performance of the male pig comprising the edited chromosomal sequence is improved. 18. The method of claim 17 , wherein the editing is by use of a TALEN, a zinc finger nuclease, or a CRISPR system. 19. The method of claim 17 , wherein the generating comprises use of somatic cell nuclear transfer. 20. The method of claim 17 , wherein the edited chromosomal sequence comprises a substitution, insertion, or deletion of one or more nucleotides in the SSTR2 coding sequence.
Knock-out vertebrates · CPC title
in mammalian cells · CPC title
inducing loss of function, i.e. knock out · CPC title
Animal model comprising inducible/conditional expression system, e.g. hormones, tet · CPC title
Swine · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.